You are here: Industry Insights > NHS

News List

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS europeanpharmaceuticalreview
August 27, 2020
The European Commission and European Medicines Agency have approved the triple combination Kaftrio for use in certain cystic fibrosis patients, triggering the drug to be accessible on the UK’s National Health Service.
Gov unveils fund for follow-on care pharmatimes
August 24, 2020
The government has announced a fund of £588 million for people needing follow-on care after being discharged from hospital.
CMOs urge trusts to continue recruiting for RECOVERY trial pharmatimes
August 21, 2020
The UK’s four Chief Medical Officers (CMOs) and NHS England and Improvements’ National Medical Director are urging NHS trusts across the country to continue recruiting high numbers of COVID-19 patients into the RECOVERY trial.
The end of Public Health England? pharmatimes
August 18, 2020
Health secretary Matt Hancock will announce this week that Public Health England (PHE) will be replaced by a new agency tasked with protecting the country from pandemics, according to media reports.
Doctors express concern over clearing NHS bottleneck pharmatimes
August 18, 2020
More than 70% of doctors feel it is unlikely that the NHS will resume a near-normal service by Autumn, a survey by the British Medical Association has revealed.
Demand for mental health services to rise due to COVID-19, report finds pharmatimes
August 13, 2020
A report from the NHS Confederation has forecast that the peak in demand for mental healthcare in England is yet to come as the effects of the coronavirus pandemic continue to have an impact.
NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments pharmatimes
August 05, 2020
NHS chief executive Sir Simon Stevens has announced plans for a £160m initiative to roll-out ‘COVID-friendly’ cancer treatments for patients across the UK.
NICE rejects NHS funding for Kyowa Kirin's Poteligeo pharmatimes
July 31, 2020
NICE is not recommending NHS funding for Kyowa Kirin's Poteligeo (mogamulizumab) as a treatment for mycosis fungoides or Sézary syndrome for adults who have had at least one previous systemic treatment.
NHS People Plan to address new pandemic challenges pharmatimes
July 31, 2020
NHS England has launched a new drive to put staff wellbeing at the heart of NHS recovery, with measures designed to address new pandemic challenges and improve physical and mental health support for staff.
Gov unveils new anti-obesity measures pharmatimes
July 28, 2020
The government has revealed a package of new measures falling under its new Obesity Strategy that are designed to improve health, ease the related burden on the NHS, and strengthen the public's resilience to COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page